Advertisement

Kardiovaskuläre Probleme und Hypertonie nach Nierentransplantation

  • Rudolf Peter Wüthrich

Zusammenfassung

Da sich in den letzten 30 Jahren die Transplantat- und Patientenüberlebensdauer nach Nierenverpflanzung ständig verbessert hat, muß heutzutage immer mehr auf die längerfristigen Komplikationen Rücksicht genommen werden. Unter diesen Komplikationen sind vor allem die kardiovaskulären Krankheiten zu nennen, die neben Krebs und Infektionen eine der wichtigsten Todesursachen nach Nierentransplantation darstellen (9, 10).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Allen RD, Michie CA, Morris PJ, Chapman JR (1985) Venous thrombosis and cyclosporin. Lancet 2: 1004PubMedCrossRefGoogle Scholar
  2. 2.
    Arnadottir M, Bergentz SE, Bergqvist D, Husberg B, Konrad P, Lindholm T (1983) Thromboembolic complications after renal transplantation: a retrospective analysis. World J Surg 7: 757PubMedCrossRefGoogle Scholar
  3. 2a.
    Ballantyne CM, Podet EJ, Patsch WP, Harati Y, Appel V, Gotto AM, Young JB (1989) Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA 262: 53PubMedCrossRefGoogle Scholar
  4. 3.
    Brown WE (1990) Long-term complications of renal transplantation. Kidney Int 37: 1363CrossRefGoogle Scholar
  5. 4.
    Brown WE et al. (1984) Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 16: 603Google Scholar
  6. 5.
    Curtis JJ (1986) Hypertension and kidney transplantation. Am J Kid Dis 7: 181PubMedGoogle Scholar
  7. 6.
    Curtis JJ (1992) Cyclosporine and posttransplant hypertension. J Am Soc Nephrol 2 (suppl 3): S243PubMedGoogle Scholar
  8. 6a.
    First MR, Neylan JF, Rocher LL, Tejani A (1994) Hypertension after renal transplantation. J Am Soc Nephrol 4 (suppl 1): S30PubMedGoogle Scholar
  9. 7.
    Gruber SA, Pescovitz MD, Simmons RL, Najarian JS, Ascher NL, Payne WD, Sutherland DER, Fryd DS (1987) Thromboembolic complications in renal allograft recipients. Transplantation 44: 775PubMedCrossRefGoogle Scholar
  10. 8.
    Kasiske BL (1988) Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84: 985PubMedCrossRefGoogle Scholar
  11. 9.
    Mahoney JF (1989) Long-term results and complications of transplantation: The kidney. Transplant Proc 21: 1433Google Scholar
  12. 9a.
    Radhakrishnan J, Williams GS, Appel GB, Cohen DJ (1994) Renal transplantation in anti- cardiolipin antibody-positive lupus erythematosus patients. Am J Kid Dis 23: 286PubMedGoogle Scholar
  13. 10.
    Raine AEG (1988) Cardiovascular complications after renal transplantation. In: Morris PJ (ed) Kidney transplantation, chap 24. Saunders, Philadelphia, pp 575–601Google Scholar
  14. 10a.
    Schwieger J, Reiss R, Cohen JL, Adler L, Makoff D (1993) Acute renal allograft dysfunction in the setting of deep venous thrombosis: a case of successful urokinase thrombolysis and a review of the literature. Am J Kidney Dis 22: 345PubMedGoogle Scholar
  15. 11.
    Thompson JF, Wood RFM, Taylor HM, Fletcher EWL, Chalmers DHK, Benjamin IS (1984) Control of hypertension after renal transplantation by embolisation of host kidneys. Lancet 2: 424PubMedCrossRefGoogle Scholar
  16. 12.
    Vanrenterghem Y et al. (1985) Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 1: 999PubMedCrossRefGoogle Scholar
  17. 13.
    Waltzer WC, Turner S, Frohnert P, Rapaport FT (1986) Etiology and pathogenesis of hypertension following renal transplantation. Nephron 42: 102PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • Rudolf Peter Wüthrich
    • 1
  1. 1.Departement für innere Medizin Abt. für NephrologieUniversitätsspital ZürichZürichSwitzerland

Personalised recommendations